Metrics
3 readers on Mendeley
The Osteoarthritis Initiative (OAI) is a public-private partnership supported through National Institutes of Health (NIH) contracts N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, and N01-AR-2-2262 and conducted by the OAI investigators. The study was primarily funded by the NIH, with additional support from private industry partners including Merck Research Laboratories, Novartis Pharmaceuticals, GlaxoSmithKline, and Pfizer. This manuscript used publicly available OAI datasets, and the findings presented do not necessarily represent the views of the OAI investigators, the NIH, or the private funding partners.